Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Ginestier

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Bulletin Du Cancer|March 1, 2003
[Tissue microarrays a powerful tool in transfer and quality control in oncology]Jocelyne Jacquemier, Christophe Ginestier, François Bertucci, et al.
International Journal of Oncology|July 16, 2004
Basal and luminal breast cancers: basic or luminous? (review)Daniel Birnbaum, François Bertucci, Christophe Ginestier, et al.
STAR Protocols|February 28, 2023
Production of CRISPRi-engineered primary human mammary epithelial cells with baboon envelope pseudotyped lentiviral vectorsSonia Pastor, Julien Wicinski, Emmanuelle Charafe-Jauffret, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 12, 2008
Cancer stem cells in breast: current opinion and future challengesEmmanuelle Charafe-Jauffret, Florence Monville, Christophe Ginestier, et al.
Plos One|September 27, 2017
HTS-Net: An integrated regulome-interactome approach for establishing network regulation models in high-throughput screeningsClaire Rioualen, Quentin Da Costa, Bernard Chetrit, et al.
Medecine Sciences : M/S|December 25, 2007
[The cancer stem cell: the breast cancer driver]Christophe Ginestier, Hasan Korkaya, Gabriela Dontu, et al.
Medecine Sciences : M/S|July 17, 2007
[Towards an integrated cellular and molecular: definition of breast cancers]Emmanuelle Charafe-Jauffret, Max Chaffanet, François Bertucci, et al.
Iscience|December 17, 2021
CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanismJean-Philippe Guégan, Justine Pollet, Christophe Ginestier, et al.
International Journal of Oncology|October 8, 2005
How to best classify breast cancer: conventional and novel classifications (review)Emmanuelle Charafe-Jauffret, Christophe Ginestier, Florence Monville, et al.
Annales De Pathologie|April 20, 2004
[Small but high throughput: how "tissue-microarrays" became a favorite tool for pathologists and scientists]Jocelyne Jacquemier, Christophe Ginestier, Emmanuelle Charafe-Jauffret, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Bulletin Du Cancer|March 1, 2003
[Tissue microarrays a powerful tool in transfer and quality control in oncology]Jocelyne Jacquemier, Christophe Ginestier, François Bertucci, et al.
International Journal of Oncology|July 16, 2004
Basal and luminal breast cancers: basic or luminous? (review)Daniel Birnbaum, François Bertucci, Christophe Ginestier, et al.
STAR Protocols|February 28, 2023
Production of CRISPRi-engineered primary human mammary epithelial cells with baboon envelope pseudotyped lentiviral vectorsSonia Pastor, Julien Wicinski, Emmanuelle Charafe-Jauffret, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 12, 2008
Cancer stem cells in breast: current opinion and future challengesEmmanuelle Charafe-Jauffret, Florence Monville, Christophe Ginestier, et al.
Plos One|September 27, 2017
HTS-Net: An integrated regulome-interactome approach for establishing network regulation models in high-throughput screeningsClaire Rioualen, Quentin Da Costa, Bernard Chetrit, et al.
Medecine Sciences : M/S|December 25, 2007
[The cancer stem cell: the breast cancer driver]Christophe Ginestier, Hasan Korkaya, Gabriela Dontu, et al.
Medecine Sciences : M/S|July 17, 2007
[Towards an integrated cellular and molecular: definition of breast cancers]Emmanuelle Charafe-Jauffret, Max Chaffanet, François Bertucci, et al.
Iscience|December 17, 2021
CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanismJean-Philippe Guégan, Justine Pollet, Christophe Ginestier, et al.
International Journal of Oncology|October 8, 2005
How to best classify breast cancer: conventional and novel classifications (review)Emmanuelle Charafe-Jauffret, Christophe Ginestier, Florence Monville, et al.
Annales De Pathologie|April 20, 2004
[Small but high throughput: how "tissue-microarrays" became a favorite tool for pathologists and scientists]Jocelyne Jacquemier, Christophe Ginestier, Emmanuelle Charafe-Jauffret, et al.
Pageof 10